Timothy Pluard
Advertisement
Articles by Timothy Pluard
15 Updated Expert Consensus Recommendations for Managing Hyperglycemia and Rash in Patients With PIK3CA-Mutated, Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2–) Advanced Breast Cancer Treated With Alpelisib
ByEmily J. Gallagher,Heather Moore,Mario E. Lacouture, MD,Susan F. Dent,Azeez Farooki, MD,Marcus D. Goncalves,Claudine Isaacs, MD,Abigail Johnston,Dejan Juric,Zoe Quandt,Laura Spring,Brian Berman,Melanie Decker,Gabriel N. Hortobagyi, MD, FACP,Benjamin H. Kaffenberger,Bernice Y. Kwong,Timothy Pluard,Ruta Rao, MD,Lee Schwartzberg, MD, FACP,Michael S. Broder
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Poorer Outcomes Observed for Black Patients Undergoing Chemotherapy for AML
2
Epcoritamab Combo Significantly Improves Efficacy in 2L R/R Follicular Lymphoma
3
Early Efficacy Highlighted With Odronextamab/CHOP in Untreated DLBCL
4
Survival Benefit Seen With Cilta-Cel in Earlier Lines of Myeloma Treatment
5
